Speaker Details 

Donato Bonifazi

CEO, CVBF

Donato Bonifazi is an Economist and the Chief Executive Officer of CVBF, a non-profit research consortium with 25 years’ experience in health and pharmaceutical research, acting as a Sponsor or a Partner/CRO in clinical research. He has been Trial Leader of two EU-funded multinational paediatric clinical trials between 2011–2017 and project coordinator of the EU-funded project DEEP – DEferiprone Evaluation in Paediatrics (FP7 GA 241683), involving 32 clinical centers from European and Mediterranean countries.

He is involved in several projects aimed at enhancing research for paediatric and rare diseases patients (i.e. OrphaDev4Kids aimed to foster the development of paediatric medical devices, ERDERA the EU Rare Disease Research Partnership, ERAMET and INVENTS, aimed at developing innovative trial methodologies for unmet needs) and is Coordinator of EPTRI (European Paediatric Translational Research Infrastructure) aimed to enhance technology-driven paediatric research in drug discovery and early development phases to be translated into clinical research and paediatric use of medicines, diagnostics and devices.

He is Board Member at TEDDY – European Network of Excellence for Paediatric Clinical Research, Member of the Coordinating Group at Enpr-EMA, Member of the ACT EU multi-stakeholder platform Advisory Group, Member of the international Children Advisory Network (iCAN) Advisory Group.

He has been President of the Italian Association of CROs (AICRO) between 2018–2020, and Chair of the EUCROF Events&Training WG between 2019-2024. Currently member of the AICRO Board of Directors and of the EUCROF Paediatric WG, the EFGCP Paediatric Medicines WG, the IRDiRC patient engagement WG, and Chair of the TEDDY Young Patient Engagement WG.